CHEK2 and cancer: This effect came from the regulation of cell cycle-related proteins, i.e., increased phosphorylation of Chk2 (checkpoint kinase 2), Cdc25C (cell division cycle 25C), and Cdc2 (cell division cycle 2), a higher level of p27, and a lower level of cyclin D observed in cancer cells treated with juglanin [77].